Jubilant Life zooms 10% as firm gets USFDA nod for drug
Jubilant Life Sciences shares soared almost 10 per cent, to touch its 52-week high level today, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
Dec 01, 2015, 15:02 PM IST